Hericium erinaceus 'Coral Hedgehog'

Hericium erinaceus 'Coral Hedgehog' is a strain of Lion's Mane mushroom containing hericenones and erinacines, bioactive compounds that stimulate Nerve Growth Factor (NGF) synthesis in the brain. Its primary mechanism involves crossing the blood-brain barrier to upregulate NGF production, supporting neuronal growth, myelination, and cognitive function.

Origin & History

Hericium erinaceus 'Coral Hedgehog' is a cultivar variant of Lion's Mane mushroom, distinguished by its coral-like, hedgehog-shaped fruiting body. Native to temperate regions of Europe, North America, and Asia where it grows on hardwood trees, this medicinal fungus is processed through aqueous extraction for polysaccharides or ethanol extraction for bioactive compounds like erinacines and hericenones.

Historical & Cultural Context

In Traditional Chinese Medicine, Hericium erinaceus has over 1000 years of documented use for digestive issues including gastritis, ulcers, and reflux. Historical applications also include nerve tonification, immune modulation, and as an anti-cancer adjuvant for stomach, intestinal, and pancreatic conditions.

Health Benefits

• Cognitive enhancement: Small RCT (n=30) showed 3g/day improved cognitive function scores in mild cognitive impairment, though not all measures reached statistical significance
• Mood and sleep support: RCT (n=77) demonstrated 1-3g/day reduced anxiety/depression symptoms and improved sleep quality over 8 weeks
• Neuroprotection: Induces nerve growth factor synthesis through erinacines and hericenones that cross the blood-brain barrier (preclinical evidence)
• Gastrointestinal protection: Polysaccharides increase protective factors (NO, PGE2, EGF) and antioxidant enzymes (animal models)
• Potential anticancer activity: In vitro studies show apoptosis induction and cell cycle arrest in gastric/colon cancer cells

How It Works

Erinacines (diterpenes found in the mycelium) cross the blood-brain barrier and stimulate NGF synthesis by activating the ERK1/2 and PI3K/Akt signaling pathways in astrocytes and neurons. Hericenones (isoindolinone derivatives from the fruiting body) further potentiate NGF secretion, promoting neuronal differentiation, axonal elongation, and remyelination. Additionally, polysaccharide fractions from H. erinaceus exhibit anti-neuroinflammatory effects by suppressing NF-κB signaling and reducing pro-inflammatory cytokines including TNF-α and IL-6.

Scientific Research

Human clinical evidence for Hericium erinaceus is limited to small RCTs with no meta-analyses available. A double-blind, placebo-controlled trial (n=30) tested 3g/day for 16 weeks on cognitive function, while another RCT (n=77) examined mood effects using 1-3g/day for 8 weeks, though full blinding details were not provided. Most evidence remains at the preclinical or animal model stage.

Clinical Summary

A small double-blind RCT (n=30) found that 3g/day of H. erinaceus fruiting body powder improved cognitive function scores in adults with mild cognitive impairment over 16 weeks, though not all measured cognitive domains reached statistical significance, limiting firm conclusions. A separate RCT (n=77) demonstrated that 1–3g/day reduced self-reported anxiety and depression symptom scores and improved sleep quality over four weeks compared to placebo. The existing human trial evidence is promising but constrained by small sample sizes, short durations, and heterogeneous outcome measures, necessitating larger Phase III trials before definitive efficacy claims can be made. Current evidence is strongest for mild cognitive impairment and mood support, with neuroregeneration and dementia prevention remaining largely preclinical findings.

Nutritional Profile

Hericium erinaceus (Lion's Mane) fruiting body contains approximately 20-25% protein (dry weight) with a favorable amino acid profile including all essential amino acids; glutamic acid and aspartic acid predominate. Carbohydrates constitute 50-60% dry weight, with beta-glucans (notably β-1,3/1,6-glucans) comprising 20-25% of dry weight as primary bioactive polysaccharides. Dietary fiber content is high at 15-30% dry weight. Fat content is low at 2-5% dry weight, predominantly unsaturated fatty acids including linoleic acid. Key bioactive compounds include erinacines (A, B, C, D, E, F, G, H, I — diterpenoids found primarily in mycelium, with erinacine A being most studied for NGF induction at concentrations ~0.05-0.5 mg/g dry mycelium) and hericenones (C, D, E, F, G, H — aromatic compounds found in fruiting body at ~0.01-0.1 mg/g dry weight). Mineral content includes potassium (~4,000 mg/100g dry), phosphorus (~1,000 mg/100g dry), zinc (~2-8 mg/100g dry), iron (~4-6 mg/100g dry), and selenium (~0.1-0.5 mg/100g dry). B-vitamins present include niacin (B3, ~60-100 mg/100g dry), riboflavin (B2, ~4-6 mg/100g dry), and pantothenic acid (B5, ~10-20 mg/100g dry). Ergosterol (provitamin D2 precursor) present at ~1-5 mg/g dry weight, converting to vitamin D2 upon UV exposure. Bioavailability note: Erinacines are lipophilic and show better absorption with dietary fat; beta-glucan bioavailability is enhanced by hot-water extraction vs. raw powder; mycelium-sourced products contain significantly higher erinacine concentrations than fruiting body alone, while fruiting bodies contain higher hericenone levels. Standard commercial extracts are typically standardized to >30% polysaccharides, though erinacine/hericenone content varies considerably by source and extraction method.

Preparation & Dosage

Clinically studied dosages include 1-3g/day of powdered fruiting body for cognitive and mood benefits. Polysaccharide extracts typically standardized to 20-30% polysaccharides, with animal studies using 200mg/kg (equivalent to 1-2g human dose). No standardization details available from human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bacopa monnieri, Rhodiola rosea, Phosphatidylserine, Omega-3 fatty acids, Ginkgo biloba

Safety & Interactions

Hericium erinaceus is generally well tolerated; the most commonly reported adverse effects are mild gastrointestinal symptoms including nausea, bloating, and abdominal discomfort, particularly at doses above 3g/day. Rare cases of allergic dermatitis and respiratory hypersensitivity have been documented, so individuals with mushroom allergies should exercise caution. H. erinaceus may have additive effects with anticoagulant or antiplatelet medications (e.g., warfarin, aspirin) due to observed platelet aggregation inhibition in preclinical models, and patients on such drugs should consult a physician before use. Safety data in pregnant or breastfeeding women is insufficient to establish a risk profile, and use is not recommended during pregnancy without medical supervision.